财新传媒
财新英文 > 要闻 > 正文

Cover Story: The Miracle and Mirage of Weight Loss Drugs

By Cui Xiaotian, Zhao Jinzhao, Zhou Xinda, Hua Ang, Cheng Xi, Tan Chen and Han Wei
2023年11月06日 08:49
With more than half the adult population of China overweight or obese, the rush is on to secure prescriptions for drugs like semaglutide – better known as Ozempic

Liu Ping, a 25-year-old living in Beijing, is queuing up outside the obesity clinic of the Peking University People’s Hospital early one morning, seeking a doctor’s prescription for the so-called “skinny jab” — a weight loss drug that has created a buying frenzy in China, where half the adults out of a total population of 1.4 billion are either overweight or obese.

  [财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]

责任编辑:bob | 版面编辑:喻竹杨洋

图片推荐

视听推荐

财新网主编精选版电邮 样例
财新网新闻版电邮全新升级!财新网主编精心编写,每个工作日定时投递,篇篇重磅,可信可引。
订阅